News Daily News New Platelet Function, Genetic Testing Consensus Seeks to Fill Gaps—Again Yael L. Maxwell November 27, 2024
Presentation AHA 2024 Effects of Sacubitril-Valsartan on Prevention of Cardiotoxicity in High-Risk Patients Undergoing Anthracycline Chemotherapy: The SARAH Trial Presenter: Marcely Gimenes Bonatto November 18, 2024
News Conference News AHA 2024 ARNI Lessens Anthracycline Cardiotoxicity in High-Risk Patients: SARAH Caitlin E. Cox November 18, 2024
News Conference News AHA 2024 Intensive BP Lowering in Diabetes Reduces CV Events: BPROAD Yael L. Maxwell November 16, 2024
News Conference News AHA 2024 Lipid Fluctuations Over Time May Portend Dementia: ASPREE Yael L. Maxwell November 15, 2024
News Daily News Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key Todd Neale November 13, 2024
News Daily News High Lp(a) Linked to ASCVD Risk Even When LDL Cholesterol Is Low Michael O'Riordan November 13, 2024
News Daily News Rosuvastatin Bests Atorvastatin for Reducing CVD Risk: Registry Data Michael O'Riordan November 07, 2024
News Conference News TCT 2024 Colchicine Surprise: No Help Post-MI, Large CLEAR SYNERGY Trial Shows Michael O'Riordan October 29, 2024
News Daily News SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients L.A. McKeown October 23, 2024
News Daily News Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge L.A. McKeown October 15, 2024
News Daily News Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime Michael O'Riordan October 14, 2024
News Daily News AHA Statement Outlines Cardiac Contributions to Brain Health L.A. McKeown October 11, 2024
News Conference News EACTS 2024 Will Semaglutide Change Cardiac Surgery? It Already Has Yael L. Maxwell October 10, 2024
News Daily News CVD Risk Twofold Higher in Patients With Cancer: ASPREE Michael O'Riordan September 27, 2024
News Daily News High Levels of Metals, Particularly Cadmium, Linked to Subclinical CVD Michael O'Riordan September 23, 2024